Amin Pharmaceutical Company
Amin Pharmaceutical Company is a Tehran Stock Exchange-listed pharmaceutical manufacturer founded in 1986 and based in Isfahan Industrial Zone, Iran. It produces tablets, capsules, syrups, suspensions, ointments, creams, gels and suppositories for the domestic market. The company is relevant to investors and supply-chain counterparties tracking Iranian medicine manufacturing, regulated pricing and imported-input exposure.
Operations & footprint
Products and services
Amin Pharmaceutical Company manufactures pharmaceutical preparations, including solid, semi-solid, and liquid dosage forms for common therapeutic categories. Its operations support pharmacy supply, hospital demand, domestic drug manufacturing, contract or licensed production, raw-material import substitution, and healthcare-sector distribution from its Isfahan-based industrial platform.
Operations and assets
The company operates a pharmaceutical manufacturing platform in Isfahan Industrial Zone producing solid, liquid, semi-solid and suppository dosage forms.
Geographic footprint
Iran, with operations based in Isfahan and a primary focus on the domestic market.
Commercial and investment relevance
Amin Pharmaceutical is relevant for investors assessing Iran's listed drug-manufacturing sector, domestic healthcare demand, pharmaceutical import substitution, and the operating economics of medicine producers outside Tehran. It can support analysis of raw-material procurement, distributor receivables, product registration, pricing policy, and resilience during medicine shortages. Due diligence should review updated financial statements, product mix, API sourcing, GMP compliance, export channels, ownership, working capital, and exposure to currency or reimbursement delays. Amin Pharmaceutical supplies a broad range of dosage formats to Iran’s medicines market. For pharmaceutical buyers and supply-chain partners, its relevance lies in domestic formulation and manufacturing capability across oral, liquid and topical products.
Constraints, risk & compliance
Key risks and constraints
Imported pharmaceutical raw materials expose production costs and continuity to foreign-exchange movements and import restrictions. Regulated medicine pricing can constrain margin recovery when input costs rise. The company also competes in Iran’s domestic pharmaceutical market.
Sanctions and compliance considerations
Its reliance on imported pharmaceutical raw materials creates compliance and supply-chain exposure where international restrictions affect sourcing, payments or logistics.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Amin Pharmaceutical Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Amin Pharmaceutical Company manufacture?
Amin Pharmaceutical Company manufactures tablets, capsules, syrups, suspensions, ointments, creams, gels and suppositories.
Where is Amin Pharmaceutical Company located?
The company is based in Isfahan Industrial Zone, Isfahan, Isfahan Province, Iran.
Is Amin Pharmaceutical Company publicly listed?
Yes. Amin Pharmaceutical Company is listed on the Tehran Stock Exchange under the symbol دامین (DAMN).
What are the main operating constraints for Amin Pharmaceutical Company?
Key constraints include imported raw-material exposure, foreign-exchange and import restrictions, and regulated medicine pricing in Iran.